India, May 12 -- Torrent Pharmaceuticals, in continuation of its earlier communication dated 24th January 2025, has informed that Dr. Maurice Chagnaud has concluded his tenure as an Independent Director of the Company on 10th May 2025, in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Following the completion of his term, Dr. Chagnaud has ceased to be a Director on the Board of Torrent Pharmaceuticals.
Published by HT Digital Content Services with permission from Dion Global Solutions Limited....